CAR-NK Cells Targeting HER1 (EGFR) Show Efficient Anti-Tumor Activity against Head and Neck Squamous Cell Carcinoma (HNSCC)

SIMPLE SUMMARY: Despite new therapeutic approaches in the last decades, prognosis and survival rates for head and neck squamous cell carcinomas (HNSCC) remain poor. Due to its high immune cell infiltration, immunotherapy has become a valuable tool for HNSCC, yet only three monoclonal antibodies have...

Descripción completa

Detalles Bibliográficos
Autores principales: Nowak, Juliette, Bentele, Marco, Kutle, Ivana, Zimmermann, Katharina, Lühmann, Jonathan Lukas, Steinemann, Doris, Kloess, Stephan, Koehl, Ulrike, Roßberg, Willi, Ahmed, Amed, Schaudien, Dirk, Neubert, Lavinia, Kamp, Jan-Christopher, Kuehnel, Mark P., Warnecke, Athanasia, Schambach, Axel, Morgan, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296665/
https://www.ncbi.nlm.nih.gov/pubmed/37370779
http://dx.doi.org/10.3390/cancers15123169

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296665/
https://www.ncbi.nlm.nih.gov/pubmed/37370779
http://dx.doi.org/10.3390/cancers15123169

Ejemplares similares